Skip to main content
Clinical Trials/NCT01723215
NCT01723215
Completed
N/A

Prevention of Posttraumatic Symptoms in IDF Soldiers Using Attention Bias Modification (ABM): A Randomized Controlled Trial

Tel Aviv University1 site in 1 country862 target enrollmentDecember 2012
ConditionsPTSD

Overview

Phase
N/A
Intervention
Not specified
Conditions
PTSD
Sponsor
Tel Aviv University
Enrollment
862
Locations
1
Primary Endpoint
Changes in PTSD symptoms(PCL)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Military deployment to combat zones involves exposure to trauma at a higher than average rate and therefore presents a unique opportunity to study predisposing factors to posttraumatic stress reactions and test strategies designed to prevent and ameliorate posttraumatic symptoms. Decades of scientific research on the origins of resilience and vulnerability to combat-related posttraumatic stress symptoms revealed various predisposing and protective factors. All these factors however, offer limited opportunity for systematic pre-deployment prevention efforts. Considering the magnitude of psychological adjustment difficulties encountered by combat personnel in deployment and the limited access to existing evidence-based therapies for PTSD, the development and testing of a novel evidence-based and theory-driven prevention protocol for these problems is of considerable significance. The current study translates cognitive-neuroscience knowledge and attention bias modification research into a novel computerized training tool that could be easily delivered to soldiers during different stages of the deployment cycle. If proved efficacious in reducing risk for posttraumatic symptoms ABMT could be integrated into the Army's resilience training program. Thus, we propose a longitudinal double-blind randomized controlled study of ABMT in soldiers. We will assess attention bias and symptoms before deployment, will randomly assign soldiers to either 8 ABMT sessions, 4 ABMT sessions, 8 Placebo training sessions, or no training. Following 6 months of deployment to combat zone symptoms will be assessed again.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
February 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Factorial
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yair Bar-Haim

Professor

Tel Aviv University

Eligibility Criteria

Inclusion Criteria

  • combat soldiers

Exclusion Criteria

  • Fluent Hebrew

Outcomes

Primary Outcomes

Changes in PTSD symptoms(PCL)

Time Frame: Pre-treatment(baseline), after first deployment, 10 days after combat, 4 months after combat

1. pre-treatment 2.after first deployment 3.10 days after combat 4. 4 months after combat

Probable PTSD diagnosis(CAPS)

Time Frame: Four months after combat

Four months after combat

Secondary Outcomes

  • Changes in Depression(PHQ-9)) and Anxiety(STAI)(Pre-treatment(baseline), after first deployment, 10 days after combat, 4 months after combat)

Study Sites (1)

Loading locations...

Similar Trials